Kite Pharma Inc Stock

Stocks

17-07-12	Novartis : FDA panel backs Novartis' pioneering new cancer gene therapy	RE
15-03-27	Alibaba : U.S. biotech stocks may fall further as short interest rises	RE

17-10-03	Kite Pharma : Gilead Sciences Completes Acquisition of Kite Pharma, Inc.	BU
17-10-03	Kite Pharma : Gilead Sciences Completes Tender Offer for All Outstanding Shares of Kite Pharma, Inc.	BU
17-09-26	Kite Pharma : Gilead Sciences and Kite Pharma Announce Expiration of Hart-Scott-Rodino Waiting Period	BU
17-09-12	Kite Pharma : Companies to Watch as Biotech Makes a Comeback in 2017	PR
17-08-29	Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Kite Pharma, Inc. to Gilead Sciences, Inc. is Fair to Shareholders	BU

17-08-28	Bluebird bio : US-Pharmafirma Gilead kauft Krebsspezialisten für 12 Mrd Dollar
17-08-28	Gilead Sciences : annonce le rachat de Kite Pharma pour 11,9 milliards de dollars
17-08-28	BOURSE : Wall Street attendue en hausse à l'ouverture après le passage de Harvey
17-08-28	Gilead Sciences : USA-Gilead annonce le rachat de Kite Pharma pour $11,9 mds
17-08-28	Kite Pharma : Gilead va acquérir Kite Pharma pour environ $11 mds-WSJ

Manager	Title	Age	Since
Shelby Geyer DFI	Director of Finance/CFO	-	2023-08-31
Priti Hegde CTO	Chief Tech/Sci/R&D Officer	54	2023-09-30
Laura Alquist COO	Chief Operating Officer	-	2024-12-31

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
KITE PHARMA INC	-.--%	+0.27%	-	-	0
WUXI APPTEC CO., LTD.	-0.62%	-1.87%	+42.87%	+67.17%	63.77B
ARGENX SE	-0.77%	+2.64%	+12.82%	+72.81%	56.37B
LONZA GROUP AG	+1.09%	+2.05%	+20.14%	+102.44%	54.62B
IQVIA HOLDINGS INC.	-2.81%	-4.31%	+23.50%	+48.51%	44.06B
BEONE MEDICINES AG	-0.33%	-1.93%	+19.28%	+104.26%	42.11B
REVOLUTION MEDICINES, INC.	+0.55%	+2.31%	+225.14%	+840.10%	41B
GENMAB A/S	-1.69%	+30.03%	+106.70%	+95.24%	34.92B
CELLTRION, INC.	+1.22%	-1.44%	+14.57%	+47.05%	32.82B
INSMED INCORPORATED	+0.89%	+20.55%	-40.62%	+350.50%	24.7B
Average	-0.26%	+7.54%	+47.15%	+192.01%	43.82B
Weighted average by Cap.	-0.36%	+5.44%	+47.76%	+173.66%

Employees

Sector